CI-Strategy provides strategic and tactical consulting services that focus on the global pharmaceutical and biotechnology markets as well as the U.S. Health Care market.
The U.S. health care market is undergoing unprecedented change. At 18% of U.S. GDP and rising, it has to alter course. Cost pressures, radical new drug and digital technologies, plus political and economic forces are driving change in virtually every sector. In addition, the U.S. economy accounts for nearly a quarter of global GDP and is too large to be immune from global forces.
In today’s market, the pressure for change is coming from all directions. As a result, it is essential that drug manufacturers and healthcare companies have 20/20 peripheral vision. They need to understand that radical new strategic and tactical opportunities and threats are on the horizon and will come from unexpected quarters.
CI-Strategy was founded on the principle of helping clients maintain a broad strategic view of the market while also focusing on today’s tactical competitive issues. In today’s rapidly changing market, it is essential that healthcare companies maintain this dual persepctive to ensure they are not blindsided.
Mike Ratcliffe, President, MA (Oxon)
Mike established CI-Strategy in 2012 based on his wide experience in global strategic and tactical consulting. Educated at Christ Church, Oxford University England, Mike graduated in physics. Following this, he studied at the London School of Economics helping him bring a combination of qualitative and quantitative real-world research skills and out-of-the-box thinking to clients. He has worked for a number of leading strategic consulting firms including DRI-McGraw Hill, Stanford Research Institute Consulting and McKinsey & Co. Fifteen years ago he made his specialty the pharmaceutical and U.S. health care market. For the seven years prior to CI-Strategy, he guided the Healthcare Practice of the competitive intelligence firm, Fuld & Co., as U.S. Research Director.
Before moving to the U.S.A., he consulted and worked in global markets. Starting in British Petroleum, he became fascinated with the global trade and the shipping market, traveling widely around the world. After some years in shipping consulting, he created and launched a number of publications including Lloyd’s Shipping Economist for Lloyd’s of London Press and wrote the book “Liquid Gold Ships: A History of the Tanker Market.”
As a result, he helps CI-Strategy bring a global perspective to projects, scientific analysis of the issues and creativity in finding the best solution for clients.